Art

J-GLOBAL ID：201202228293543583   Reference number：12A1442684

Everolimus for Advanced Pancreatic Neuroendocrine Tumours: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial

進行膵神経内分泌腫瘍に対するエベロリムス:RADIANT-3試験における日本人患者を評価するサブグループ解析

Author (10)： ITO Tetsuhide (Kyushu Univ., Fukuoka) ,  OKUSAKA Takuji (National Cancer Center Hospital, Tokyo) ,  IKEDA Masafumi (National Cancer Center Hospital East, Chiba) ,  IGARASHI Hisato (Kyushu Univ., Fukuoka) ,  MORIZANE Chigusa (National Cancer Center Hospital, Tokyo) ,  NAKACHI Kohei (National Cancer Center Hospital East, Chiba) ,  TAJIMA Takeshi (Novartis Pharma K.K., Tokyo) ,  KASUGA Akio (Novartis Pharma K.K., Tokyo) ,  FUJITA Yoshie (Novartis Pharma K.K., Tokyo) ,  FURUSE Junji (Kyorin Univ. School of Medicine, Tokyo, JPN)
Material： Japanese Journal of Clinical Oncology  (JJCO)
Volume： 42  Issue： 10  Page： 903-911  Publication year： Oct. 2012 
JST Material Number： W2222A  ISSN： 0368-2811  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： mTOR inhibitor ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1442684&from=J-GLOBAL&jstjournalNo=W2222A") }}

JST classification (3)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Everolimus

Reference (27)：

• Yao JC, Eisner MP, Leary C, et al. Population-based study of islet cell carcinoma. Ann Surg Oncol 2007; 14: 3492-500.
• Yao JC, Hassan M, Phan A, et al. One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol 2008; 26: 3063-72.
• Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 2010; 45: 234-43.
• Capurso G, Fazio N, Festa S, Panzuto F, de Braud F, Delle Fave G. Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives. Grit Rev Oncol Hematol 2009; 72: 110-24.
• Basu B, Sirohi B, Corrie P. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin. Endocr Relat Cancer 2010; 17: R75-90.

Terms in the title (8)： 膵神経内分泌腫瘍 ,  エベロリムス ,  試験 ,  日本人 ,  患者 ,  評価 ,  サブ ,  グループ解析